Matches in Wikidata for { <http://www.wikidata.org/entity/Q64394871> ?p ?o ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- Q64394871 description "clinical trial" @default.
- Q64394871 description "ensayu clínicu" @default.
- Q64394871 description "klinisch onderzoek" @default.
- Q64394871 description "клінічне випробування" @default.
- Q64394871 name "Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy" @default.
- Q64394871 type Item @default.
- Q64394871 label "Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy" @default.
- Q64394871 prefLabel "Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy" @default.
- Q64394871 P1132 Q64394871-D07552E9-EAB2-49AF-94BD-3847C133B4EF @default.
- Q64394871 P1476 Q64394871-F2E3617A-6B28-41A7-9147-BF4AD0D063D9 @default.
- Q64394871 P17 Q64394871-F9D14847-3A9C-4560-8DA4-F1BB523435B7 @default.
- Q64394871 P2899 Q64394871-F9878D53-D083-48FB-B559-AD1A98B6DE6B @default.
- Q64394871 P3098 Q64394871-C56CE36E-CD61-4756-A0B6-3B6F5D5C1A80 @default.
- Q64394871 P31 Q64394871-3BD49D2F-1158-4A84-A28C-9488170318C3 @default.
- Q64394871 P4844 Q64394871-1E9ADFCA-A63E-400A-A45D-D54C99079E8A @default.
- Q64394871 P580 Q64394871-1E3E009F-6C90-48B8-932C-EDD6E4F9BDF2 @default.
- Q64394871 P582 Q64394871-4B2B6FE9-0564-499D-BA72-9AF8722C5CD4 @default.
- Q64394871 P6099 Q64394871-2D581787-B4BF-42C6-8FF1-A7FF48BE2EDA @default.
- Q64394871 P6153 Q64394871-3E46624B-EDEB-4686-BF51-AC31A188D339 @default.
- Q64394871 P8363 Q64394871-887A1591-6D98-4E65-99E3-195E234421ED @default.
- Q64394871 P1132 "+15" @default.
- Q64394871 P1476 "A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy" @default.
- Q64394871 P17 Q30 @default.
- Q64394871 P2899 "+18" @default.
- Q64394871 P3098 "NCT02427581" @default.
- Q64394871 P31 Q30612 @default.
- Q64394871 P4844 Q7226111 @default.
- Q64394871 P580 "2015-09-29T00:00:00Z" @default.
- Q64394871 P582 "2020-08-31T00:00:00Z" @default.
- Q64394871 P6099 Q5452194 @default.
- Q64394871 P6153 Q7972509 @default.
- Q64394871 P8363 Q78089383 @default.